Shanghai, China
Nutshell Therapeutics, founded in 2013, is a promising player in the biotech sector, positioning itself at the forefront of tackling undruggable targets through innovative approaches. With the slogan, "Deciphering Undruggable by Allostery," the company aims to revolutionize drug discovery by utilizing an advanced toolbox that integrates AI and computational methods with traditional web lab techniques.
This clinical stage biotech company focuses on allosteric small molecule therapies, which are vital in treating challenging or previously undruggable targets. While the specifics of its headquarters and recent investments remain undisclosed, the company's strategic emphasis on cutting-edge technology and therapeutic innovation makes it an attractive prospect for investors seeking to capitalize on breakthroughs in drug discovery.
